Results 111 to 120 of about 1,473,533 (284)
Pregnant and breastfeeding individuals are routinely excluded from clinical drug development, creating persistent evidence gaps in pharmacology, safety, and dosing. Despite mandatory contraception and pregnancy testing, unintended pregnancies occur, particularly during the development of central nervous system (CNS) medicines used by women of ...
Sam Schoenmakers +4 more
wiley +1 more source
Is it possible to prevent excessive synaptic pruning in schizophrenia? Possibilities and limitations
BackgroundSynaptic pruning is a critical neurodevelopmental process that eliminates redundant or weak synaptic connections to optimize brain circuitry. In schizophrenia, converging evidence from imaging, genetic, and postmortem studies suggests that this
Agnieszka Pawlak +7 more
doaj +1 more source
This review highlights the misuse of antidepressants as potential cognitive‐enhancing agents in Esports. Despite pharmacological effects that overlap with those of psychostimulants, antidepressants remain an under‐recognised source of doping in Esports.
Kassim Ali Salum +4 more
wiley +1 more source
BackgroundRisperidone is one of the most reliable and effective antipsychotics for schizophrenia treatment. However, the mechanism of action of risperidone is not yet fully understood.
Ruixue Yuan +8 more
doaj +1 more source
ABSTRACT Objective Eating disorders (EDs) are characterized by high rates of psychiatric comorbidity and suboptimal treatment outcomes. There remain critical gaps in research, including the exploration of effective transdiagnostic interventions. This forum article examines the potential of psilocybin treatment (PT) as a transdiagnostic intervention for
Elena Koning +2 more
wiley +1 more source
Excess Mortality Among Patients With Anorexia Nervosa Treated Involuntarily
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder with high morbidity and increased relative mortality compared to the general population. Involuntary treatment (IT) is implemented after exhausting voluntary treatment options. This study investigates mortality in patients with AN following IT, using IT as an indicator of patient
Line Bager +6 more
wiley +1 more source
ABSTRACT Objective Anxiety and depression are highly prevalent among adolescents and young adults with eating disorders. A comorbid mental health condition is associated with worsened long‐term eating disorder outcomes. While individual risk factors for comorbid anxiety or depression and eating disorders have been elucidated, the impact of external ...
Anita V. Chaphekar +3 more
wiley +1 more source
Two bipolar disorders or one? In reply to commentary by Malhi and Bell
Leonardo Tondo +4 more
doaj +1 more source
Electroencephalography (EEG) has been proposed as a neurophysiological biomarker to delineate psychotic disorders. It is known that increased delta and decreased alpha, which are apparent in psychosis, are indicative of inappropriate arousal state, which
Temmingh, H.S +5 more
core +1 more source
ABSTRACT Objective Enhanced Cognitive Behavior Therapy (CBT‐E) is the leading outpatient treatment for eating disorders but is typically delivered by a single clinician and does not routinely incorporate interprofessional expertise. In broader healthcare settings, Interprofessional collaborative practice (IPCP), characterized by role clarity, shared ...
Megan Bray +4 more
wiley +1 more source

